Recombinant Full Length Milnesium Tardigradum Aquaporin-3(Aqp3) Protein, Tag-Free

• Cat.No.: RFL15216MF
• Product Overview: Recombinant Full Length Milnesium tardigradum Aquaporin-3(AQP3) Protein (G5CTG0) (1-326aa) was expressed in E. coli.

Specification

• Source: E.coli expression system
• Species: Milnesium tardigradum (Water bear) (Tardigrade)
• Tag: Tag-Free
• Form: Lyophilized powder
• Protein length: Full Length (1-326)
• AA Sequence: MAISWRTWLKKTIHCDNSYVRTGLA EFLGTFLLVLLLNGMIITAHMSVRN ADGTMAHPLNTAHLAFGGGLAVMVA VLVSGGISGAHLNPAVTTTMLVMGR LSPLKSLVYIFMQYMGAFFAASILY AVYFESILAYDYGERQVLGANGTAG WFATYPQEHISLVTQIFDAILGTGL LVMGIFAIIDPNNMAVPKGQIPLYV GFLISSLIFSFSYNAGAALNPARDL APRLFLWVIGYGAEAFTARGHLWWL VPVIGPHVGGLLGGVTYQMFIGAHY QSDRKLKPATIMDEDDDTNATYNTI TTTTHQKVYNGRRNFDESVPLKTVH A Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
• Purity: Greater than 90% as determined by SDS-PAGE.
• Applications: SDS-PAGE
• Notes: Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
• Storage: Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
• Storage Buffer: Tris/PBS-based buffer, 6% Trehalose, pH 8.0
• Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
• Gene Name: AQP3
• Synonyms: AQP3Aquaporin-3; AQP-3
• UniProt ID: G5CTG0

Gene Information

• Gene Name: AQP3
• Synonyms: AQP3Aquaporin-3; AQP-3
• UniProt ID: G5CTG0

Reviews

02/02/2022

This level of support saves researchers time and resources, enabling them to focus on the scientific aspects of their work and accelerate the overall progress of their studies.

08/27/2021

its high quality and purity ensure accurate and reliable results.

02/02/2019

If researchers require specific variants or modifications of AR protein, the manufacturer can work with them to provide customized products tailored to their needs.

06/30/2018

Manufacturers may offer the option for custom protein production.

03/06/2018

The AQP3 protein exhibits several valuable attributes that make it an excellent choice for my trials.

04/17/2017

With the manufacturer's unwavering dedication to delivering quality products and unparalleled technical support, I am confident in their ability to help me overcome any challenges and propel my research forward.

04/17/2017

the stability of the AQP3 protein enables me to conduct experiments over an extended period, reducing the need for frequent restocking and promoting experimental consistency.

01/10/2016

Their expertise can help troubleshoot problems, suggest alternative approaches, or provide recommendations for optimizing experimental protocols.

Q&As

Are there any known disorders or conditions associated with AQP3 dysfunction?

Yes, mutations or alterations in the AQP3 gene have been associated with several skin disorders, including palmoplantar keratoderma and porokeratosis. These conditions are characterized by abnormal skin thickening and the formation of scaly patches.

Is genetic testing available for AQP3-related disorders?

Yes, genetic testing can be conducted to identify mutations in the AQP3 gene that may be associated with specific skin disorders. This testing can help with diagnosis and provide valuable information for understanding the underlying cause of the condition.

Can lifestyle factors or environmental factors affect AQP3 activity?

Yes, certain lifestyle factors and environmental conditions can influence AQP3 activity. For example, exposure to ultraviolet radiation from sunlight can upregulate AQP3 expression in the skin, potentially affecting skin hydration and barrier function. Additionally, some studies suggest that certain drugs, such as retinoids, may modulate AQP3 expression and function.

Can AQP3 dysfunction lead to any other health issues?

AQP3 dysfunction may be involved in the development of some metabolic disorders and certain types of cancer. Dysregulation of AQP3 expression or activity has been linked to altered water transport and cell proliferation, which can contribute to disease progression.

Does AQP3 play a role in the regulation of body temperature?

While AQP3 primarily functions as a water transporter, there is evidence suggesting its involvement in thermoregulation. Studies have shown that AQP3 expression increases in response to heat exposure, and it may facilitate the movement of water and thermal energy across the skin, contributing to cooling mechanisms in the body.

Does AQP3 play a role in the regulation of body temperature?

While AQP3 primarily functions as a water transporter, there is evidence suggesting its involvement in thermoregulation. Studies have shown that AQP3 expression increases in response to heat exposure, and it may facilitate the movement of water and thermal energy across the skin, contributing to cooling mechanisms in the body.

Can AQP3 be targeted for therapeutic purposes?

AQP3 has been investigated as a potential therapeutic target in various contexts. For example, in dermatology, compounds that modulate AQP3 activity are being explored for their ability to improve skin hydration and barrier function. In cancer research, inhibiting AQP3 expression or activity has shown potential in impeding tumor growth and metastasis.

Can AQP3 be targeted for therapeutic purposes?

AQP3 has been investigated as a potential therapeutic target in various contexts. For example, in dermatology, compounds that modulate AQP3 activity are being explored for their ability to improve skin hydration and barrier function. In cancer research, inhibiting AQP3 expression or activity has shown potential in impeding tumor growth and metastasis.

Can AQP3 dysfunction affect the hydration of the skin?

Yes, alterations in AQP3 function or expression can impact skin hydration. Decreased AQP3 activity has been associated with impaired water transport across skin cells, leading to decreased skin hydration and potentially contributing to dry skin conditions.

Can AQP3 dysfunction affect the hydration of the skin?

Yes, alterations in AQP3 function or expression can impact skin hydration. Decreased AQP3 activity has been associated with impaired water transport across skin cells, leading to decreased skin hydration and potentially contributing to dry skin conditions.

Are there any treatments available for AQP3-related disorders?

Currently, there are no specific targeted treatments available for AQP3-related disorders. However, management of symptoms and complications associated with these conditions may involve moisturizers, topical medications, and other dermatological interventions to help alleviate skin-related issues.

Is AQP3 expressed only in humans?

No, AQP3 is not exclusive to humans. It is found in various animal species, including mammals, birds, and reptiles. Its presence in different organisms suggests its evolutionary significance in water balance regulation and other biological processes.

How is the AQP3 protein regulated in the body?

The expression and activity of AQP3 can be regulated by various factors. Hormones, such as glucocorticoids and thyroid hormones, have been shown to influence AQP3 expression in certain tissues. Additionally, signaling pathways like the cAMP-protein kinase A pathway and the MAPK pathway have been implicated in the regulation of AQP3 activity.

How is the AQP3 protein regulated in the body?

The expression and activity of AQP3 can be regulated by various factors. Hormones, such as glucocorticoids and thyroid hormones, have been shown to influence AQP3 expression in certain tissues. Additionally, signaling pathways like the cAMP-protein kinase A pathway and the MAPK pathway have been implicated in the regulation of AQP3 activity.

Are there any known inhibitors or activators of AQP3?

Several compounds have been identified as potential AQP3 inhibitors or activators. For example, some natural substances like flavonoids and polyphenols have been found to inhibit AQP3 function. Conversely, certain synthetic compounds, such as AQP3 activators 4-Chlorobenzoylisothiocyanate and phloretin, have been shown to enhance AQP3 activity.

Are there any known inhibitors or activators of AQP3?

Several compounds have been identified as potential AQP3 inhibitors or activators. For example, some natural substances like flavonoids and polyphenols have been found to inhibit AQP3 function. Conversely, certain synthetic compounds, such as AQP3 activators 4-Chlorobenzoylisothiocyanate and phloretin, have been shown to enhance AQP3 activity.

Are there any other proteins that interact with AQP3?

Yes, AQP3 can interact with other proteins within the cell. For instance, it has been shown to interact with ezrin, a cytoskeletal protein, in the kidney. This interaction may play a role in the intracellular trafficking of AQP3 and its localization to specific membrane domains.

Are there any other proteins that interact with AQP3?

Yes, AQP3 can interact with other proteins within the cell. For instance, it has been shown to interact with ezrin, a cytoskeletal protein, in the kidney. This interaction may play a role in the intracellular trafficking of AQP3 and its localization to specific membrane domains.

Can AQP3 be targeted for drug delivery purposes?

AQP3 has been explored for drug delivery applications. Due to its water transport function, it can potentially be utilized to improve the delivery of hydrophilic drugs. By understanding the mechanisms of AQP3-mediated water transport, researchers are exploring ways to engineer drug carriers that can exploit these channels for efficient drug delivery.

Can AQP3 be targeted for drug delivery purposes?

AQP3 has been explored for drug delivery applications. Due to its water transport function, it can potentially be utilized to improve the delivery of hydrophilic drugs. By understanding the mechanisms of AQP3-mediated water transport, researchers are exploring ways to engineer drug carriers that can exploit these channels for efficient drug delivery.